LWLIVING WITH T1D
Living With T1D/August 14, 2026/3 min read

How Older Adults with Type 1 Diabetes Are Finding Success with Automated Insulin Delivery

A real-world study of adults over 60 using the MiniMed 780G system shows that customized settings—not one-size-fits-all recommendations—help achieve good blood sugar control while managing age-related health concerns.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

living with t1dmental healthtechnologysupport

Key takeaways

  • Older adults using the MiniMed 780G automated insulin delivery system achieved an average time in range of 76%, showing that tight glycemic control is achievable in this age group
  • More than half of participants (56.7%) reached the tighter glucose target range of 70-140 mg/dL for over half their day, suggesting personalized algorithm settings matter
  • The manufacturer's recommended standard settings worked well for some users, but customized adjustments were equally effective—meaning there's no one 'best' setting for everyone
  • Low rates of dangerously low blood sugar (averaging 1.1% time below range) suggest that automated systems can help protect older adults from severe hypoglycemia

Balancing Control and Safety in Older Adults

Managing Type 1 diabetes in older adults requires a careful balance. While maintaining healthy blood sugar levels is important at any age, older adults also face unique risks—including falls from low blood sugar episodes and other age-related health conditions. A new real-world study published in Frontiers in Endocrinology examined how well automated insulin delivery systems work for people over 60 and what settings help them achieve the best results.

The study looked at 97 adults aged 60 and older (average age 68) who were using the MiniMed 780G automated insulin delivery (AID) system. This system uses a continuous glucose monitor and an algorithm to automatically adjust insulin doses throughout the day, reducing the burden of constant manual adjustments.

Strong Blood Sugar Control Across the Group

Overall, the older adults in the study achieved good glycemic control. On average, they spent 76% of their time with blood sugar in the target range of 70-180 mg/dL—a benchmark many diabetes teams consider successful. Even more impressively, more than half the group (56.7%) spent at least 50% of their time in a tighter target range of 70-140 mg/dL.

Perhaps most important for safety, the group spent only 1.1% of their time with dangerously low blood sugar—a significant concern for older adults, who may not recognize hypoglycemia symptoms and are at greater risk of serious complications from low blood sugar episodes.

Personalized Settings Beat One-Size-Fits-All Approaches

The MiniMed 780G system comes with manufacturer-recommended standard settings: a target glucose of 5.5 mmol/L (99 mg/dL) and an active insulin time of 2 hours. However, only 14 participants (14.4%) actually used these exact recommended settings. The rest customized their algorithms based on their individual needs.

Interestingly, blood sugar outcomes were similar whether users followed the recommended settings or made adjustments. This suggests that automated insulin delivery systems work well for older adults regardless of which specific algorithm settings they use—as long as those settings are personalized to their circumstances. This flexibility may be especially valuable for older adults managing multiple health conditions or taking other medications that affect blood sugar.

What This Means for Older Adults with Type 1 Diabetes

This study provides reassuring evidence that automated insulin delivery can help older adults achieve strong glycemic control while minimizing dangerous low blood sugar episodes. The key finding—that customized settings work as well as standard recommendations—emphasizes the importance of working with your diabetes care team to adjust your system settings to match your individual health needs and lifestyle.

If you're an older adult with Type 1 diabetes considering or already using an automated insulin delivery system, these results suggest that the technology can be an effective tool. However, success depends on regular communication with your healthcare provider to fine-tune your settings and monitor how well the system is working for you.

Evidence label

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.